{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T13:29:46Z","timestamp":1773235786876,"version":"3.50.1"},"reference-count":30,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrinolog\u00eda, Diabetes y Nutrici\u00f3n (English ed.)"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.endien.2025.501677","type":"journal-article","created":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T12:42:19Z","timestamp":1770727339000},"page":"501677","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Influence of oncostatin M and leukemia inhibitor factor on sarcopenia in individuals with cancer and malnutrition"],"prefix":"10.1016","volume":"73","author":[{"given":"Daniel","family":"de Luis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Primo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olatz","family":"Izaola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan Jos\u00e9","family":"L\u00f3pez G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.endien.2025.501677_bib0155","first-page":"1049","article-title":"Prevalencia y costes de malnutrici\u00f3n en pacientes hospitalizados; Estudio Predyces","volume":"2","author":"\u00c1lvarez Hern\u00e1ndez","year":"2012","journal-title":"Nutr Hosp"},{"key":"10.1016\/j.endien.2025.501677_bib0160","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1093\/ageing\/afq034","article-title":"Sarcopenia: European consensus on definition and diagnosis","volume":"39","author":"Cruz-Jentoft","year":"2018","journal-title":"Age Ageing"},{"key":"10.1016\/j.endien.2025.501677_bib0165","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.clnu.2008.06.013","article-title":"Cachexia: a new definition","volume":"27","author":"Evans","year":"2008","journal-title":"Clin Nutr"},{"key":"10.1016\/j.endien.2025.501677_bib0170","article-title":"The enigmatic cytokine oncostatin m and roles in disease","volume":"13","author":"Richards","year":"2013","journal-title":"ISRN Inflamm"},{"key":"10.1016\/j.endien.2025.501677_bib0175","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0022538","article-title":"STAT3 activation in skeletal muscle links muscle wasting and the acute phase response in cancer cachexia","volume":"6","author":"Bonetto","year":"2011","journal-title":"PLOS ONE"},{"key":"10.1016\/j.endien.2025.501677_bib0180","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.bbamcr.2004.11.002","article-title":"Leukemia inhibitory factor blocks early differentiation of skeletal muscle cells by activating ERK","volume":"1743","author":"Jo","year":"2005","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"10.1016\/j.endien.2025.501677_bib0185","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1038\/nm.3656","article-title":"STAT3 signaling controls satellite cell expansion and skeletal muscle repair","volume":"20","author":"Tierney","year":"2014","journal-title":"Nat Med"},{"key":"10.1016\/j.endien.2025.501677_bib0190","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.cmet.2013.07.012","article-title":"Stat3 activation links a C\/EBPdelta to myostatin pathway to stimulate loss of muscle mass","volume":"18","author":"Zhang","year":"2013","journal-title":"Cell Metabol"},{"key":"10.1016\/j.endien.2025.501677_bib0195","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.cellsig.2007.09.004","article-title":"induces growth arrest of skeletal muscle cells in G1 phase by regulating cyclin D1 protein level","volume":"20","author":"Kim","year":"2008","journal-title":"Cell Signal"},{"key":"10.1016\/j.endien.2025.501677_bib0200","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/cr.2010.144","article-title":"inhibits myoblast differentiation and regulates muscle regeneration","volume":"21","author":"Xiao","year":"2011","journal-title":"Cell Res"},{"key":"10.1016\/j.endien.2025.501677_bib0205","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1038\/s41467-018-03876-8","article-title":"Induction of muscle stem cell quiescence by the secreted niche factor Oncostatin M","volume":"9","author":"Sampath","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.endien.2025.501677_bib0210","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1530\/rep.1.00956","article-title":"Evidence for heterodimeric association of leukemia inhibitory factor (LIF) receptor and gp130 in the mouse uterus for LIF signaling during blastocyst implantation","volume":"131","author":"Song","year":"2006","journal-title":"Reproduction"},{"key":"10.1016\/j.endien.2025.501677_bib0215","doi-asserted-by":"crossref","first-page":"19976","DOI":"10.1074\/jbc.M115.638411","article-title":"A key role for leukemia inhibitory factor in c26 cancer cachexia","volume":"290","author":"Seto","year":"2015","journal-title":"J Biol Chem"},{"key":"10.1016\/j.endien.2025.501677_bib0220","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.clnu.2018.08.002","article-title":"GLIM criteria for the diagnosis of malnutrition \u2013 a consensus report from the global clinical nutrition community","volume":"38","author":"Cederholm","year":"2019","journal-title":"Clin Nutr"},{"key":"10.1016\/j.endien.2025.501677_bib0225","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1093\/ajcn\/41.4.810","article-title":"Assessment of fat-free mass using bioelectrical impedance measurements of the human body","volume":"41","author":"Lukaski","year":"1985","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.endien.2025.501677_bib0230","first-page":"74","article-title":"Nutritional ultrasound\u00ae: conceptualisation, technical considerations and standardisation","volume":"1","author":"Garc\u00eda-Almeida","year":"2022","journal-title":"Endocrinol Diabetes Nutr"},{"key":"10.1016\/j.endien.2025.501677_bib0235","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1093\/ageing\/afz046","article-title":"Sarcopenia: revised European consensus on definition and diagnosis","volume":"48","author":"Cruz-Jentoft","year":"2019","journal-title":"Age Ageing"},{"key":"10.1016\/j.endien.2025.501677_bib0240","series-title":"Tablas de composici\u00f3n de alimentos espa\u00f1oles","author":"Mataix","year":"2003"},{"key":"10.1016\/j.endien.2025.501677_bib0245","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/cr.2010.144","article-title":"Oncostatin M inhibits myoblast differentiation and regulates muscle regeneration","volume":"21","author":"Xiao","year":"2011","journal-title":"Cell Res"},{"key":"10.1016\/j.endien.2025.501677_bib0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2022.155972","article-title":"Exogenous oncostatin M induces cardiac dysfunction, musculoskeletal atrophy, and fibrosis","volume":"159","author":"Jengelley","year":"2022","journal-title":"Cytokine"},{"key":"10.1016\/j.endien.2025.501677_bib0255","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1038\/s41467-018-03876-8","article-title":"Induction of muscle stem cell quiescence by the secreted niche factor Oncostatin M","volume":"9","author":"Sampath","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.endien.2025.501677_bib0260","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1152\/ajpendo.00520.2010","article-title":"Exercise-induced muscle-derived cytokines inhibit mammary cancer cell growth","volume":"301","author":"Hojman","year":"2011","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.endien.2025.501677_bib0265","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/j.bbrc.2019.06.143","article-title":"Oncostatin M induces C2C12 myotube atrophy by modulating muscle differentiation and degradation","volume":"516","author":"Miki","year":"2019","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.endien.2025.501677_bib0270","article-title":"Oncostatin M signaling drives cancer-associated skeletal muscle wasting","volume":"5","author":"Domaniku-Waraich","year":"2024","journal-title":"Cell Rep Med"},{"key":"10.1016\/j.endien.2025.501677_bib0275","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1152\/ajpendo.00116.2013","article-title":"New cancer cachexia rat model generated by implantation of a peritoneal dissemination-derived human stomach cancer cell line","volume":"306","author":"Terawaki","year":"2014","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.endien.2025.501677_bib0280","doi-asserted-by":"crossref","first-page":"23224","DOI":"10.1074\/jbc.M801379200","article-title":"Inhibition of myoblast differentiation by tumor necrosis factor alpha is mediated by c-Jun Nterminal kinase 1 and leukemia inhibitory factor","volume":"283","author":"Alter","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1016\/j.endien.2025.501677_bib0285","doi-asserted-by":"crossref","first-page":"19976","DOI":"10.1074\/jbc.M115.638411","article-title":"A key role for leukemia inhibitory factor in C26 cancer cachexia","volume":"290","author":"Seto","year":"2015","journal-title":"J Biol Chem"},{"key":"10.1016\/j.endien.2025.501677_bib0290","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1002\/jcsm.12346","article-title":"Tumour-derived leukaemia inhibitory factor is a major driver of cancer cachexia and morbidity in C26 tumour-bearing mice","volume":"9","author":"Kandarian","year":"2018","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.endien.2025.501677_bib0295","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14122955","article-title":"The molecular basis and therapeutic potential of leukemia inhibitory factor in cancer cachexia","volume":"14","author":"Zeng","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.endien.2025.501677_bib0300","first-page":"98","article-title":"Normative reference values for hand grip dynamometry in Spain. Association with lean mass","volume":"35","author":"S\u00e1nchez Torralvo","year":"2018","journal-title":"Nutr Hosp"}],"container-title":["Endocrinolog\u00eda, Diabetes y Nutrici\u00f3n (English ed.)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2530018025001659?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2530018025001659?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T17:26:34Z","timestamp":1773163594000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2530018025001659"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S2530018025001659"],"URL":"https:\/\/doi.org\/10.1016\/j.endien.2025.501677","relation":{},"ISSN":["2530-0180"],"issn-type":[{"value":"2530-0180","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Influence of oncostatin M and leukemia inhibitor factor on sarcopenia in individuals with cancer and malnutrition","name":"articletitle","label":"Article Title"},{"value":"Endocrinolog\u00eda, Diabetes y Nutrici\u00f3n (English ed.)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.endien.2025.501677","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 SEEN and SED. Published by Elsevier Espa\u00f1a, S.L.U. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"501677"}}